nevirapine has been researched along with AIDS Seroconversion in 85 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Data from a prospective multisite cohort study were used to examine the effect of HIV exposure, untreated HIV infection, and single-dose nevirapine on infant growth velocity." | 7.80 | HIV infection, viral load, low birth weight, and nevirapine are independent influences on growth velocity in HIV-exposed South African infants. ( Chhagan, M; Doherty, T; Fadnes, LT; Goga, AE; Jackson, DJ; Lombard, C; Ramokolo, V; Van den Broeck, J, 2014) |
| "The risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregnant women." | 6.49 | Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis. ( Andrieux-Meyer, I; Calmy, A; Ford, N; Hargreaves, S; Mills, EJ; Shubber, Z, 2013) |
| "Nevirapine treatment was stopped and was substituted with efavirenz: the patient continued on therapy with tenofovir and lamivudine." | 5.38 | Hyperhidrosis related to nevirapine therapy. ( Belda, A; Borrás-Blasco, J; Casterá, E; Jiménez, I; López-Montes, L; Rosique-Robles, D, 2012) |
| "Extended nevirapine and cotrimoxazole prophylaxis through 6 months of age among HIV-exposed uninfected infants did not appear to increase the immediate or long-term risk of neutropenia, anemia or skin-rash." | 5.16 | Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated. ( Aizire, J; Bolton, SG; Brown, ER; Coovadia, H; Fowler, MG; Kamateeka, M; Musoke, PM; Shetty, AK; Stranix-Chibanda, L; Wang, J, 2012) |
| "The median [interquartile range (IQR)] age, body weight and daily nevirapine dose in 15 included children (eight girls) were 4." | 5.16 | Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets. ( Burger, DM; Chintu, C; Cook, A; Ferrier, A; Fillekes, Q; Gibb, DM; Kabamba, D; Kankasa, C; Mulenga, V; Thomason, MJ; Walker, AS, 2012) |
| "Pregnant HIV-1 seropositive women (CD4+ T-cell count >250 and <500 cells/mm3) electing to breastfeed in Nairobi, Kenya were randomized to highly active antiretroviral therapy (HAART; zidovudine [ZDV], lamivudine and nevirapine [NVP]) during pregnancy and 6 months post-partum or to short-course ZDV plus single-dose NVP (ZDV/NVP)." | 5.13 | Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial. ( Chung, MH; John-Stewart, GC; Kiarie, JN; Kinuthia, J; Lehman, DA; Njiri, F; Overbaugh, J; Richardson, BA, 2008) |
| "Treatment of human immunodeficiency virus (HIV) infection with nevirapine in patients with < 400 CD4 cells/mm3 rapidly selects for virus with reduced susceptibility to nevirapine." | 5.08 | A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of > 500/mm3: AIDS Clinical Trials Group Protocol 208. ( Havlir, D; McLaughlin, MM; Richman, DD, 1995) |
| "Data from a prospective multisite cohort study were used to examine the effect of HIV exposure, untreated HIV infection, and single-dose nevirapine on infant growth velocity." | 3.80 | HIV infection, viral load, low birth weight, and nevirapine are independent influences on growth velocity in HIV-exposed South African infants. ( Chhagan, M; Doherty, T; Fadnes, LT; Goga, AE; Jackson, DJ; Lombard, C; Ramokolo, V; Van den Broeck, J, 2014) |
| "This case is about an HIV seropositive young woman referred for the treatment of severe menorrhagia causing anaemia due to adenomyosis where the levonorgestrel-releasing intrauterine system (Mirena) proved useful in treating her heavy periods and also provided effective contraception without interference from the liver enzyme-inducing effects of antiretroviral medications." | 3.74 | Two for the price of one. ( Kumar, U; Samuel, MI; Taylor, C; Tenant-Flowers, M, 2008) |
| "46%), underweight (27% vs." | 2.77 | Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India. ( Bollinger, RC; Gupta, A; Gupte, N; Khandave, M; Kinikar, AA; Nayak, U; Ram, M; Sastry, J; Shankar, AV, 2012) |
| "Drugs most likely to interact with combined oral contraceptives, transdermal and implant contraceptives include protease inhibitors, the NNRTIs efavirenz and nevirapine, and cobicistat-boosted elvitegravir." | 2.49 | Drug interactions between antiretrovirals and hormonal contraceptives. ( Hills-Nieminen, C; Tseng, A, 2013) |
| "The risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregnant women." | 2.49 | Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis. ( Andrieux-Meyer, I; Calmy, A; Ford, N; Hargreaves, S; Mills, EJ; Shubber, Z, 2013) |
| "Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening hypersensitivity reactions mainly caused by drugs." | 1.46 | Drug-induced Stevens-Johnson syndrome in Indian population: A multicentric retrospective analysis. ( Barvaliya, MJ; Hirapara, HN; Patel, TK; Tripathi, C, 2017) |
| "Nevirapine treatment was stopped and was substituted with efavirenz: the patient continued on therapy with tenofovir and lamivudine." | 1.38 | Hyperhidrosis related to nevirapine therapy. ( Belda, A; Borrás-Blasco, J; Casterá, E; Jiménez, I; López-Montes, L; Rosique-Robles, D, 2012) |
| " The population pharmacokinetic approach represents a very useful tool for the description of the dose-concentration relationship, the quantification of variability in the target population of patients and the identification of influencing factors." | 1.38 | Dosage optimization of treatments using population pharmacokinetic modeling and simulation. ( Aouri, M; Arab-Alameddine, M; Buclin, T; Csajka, C; Decosterd, LA; Guidi, M; Rotger, M; Telenti, A, 2012) |
| "Transmission prophylaxis in offspring of HIV-positive mothers may give rise to adverse effects." | 1.34 | [Side effects of antiretroviral treatment for transmission prophylaxis in preterm and near-term infants]. ( Bauer, K; Dunsch, D; Haberl, A; Linde, R; Reitter, A; Schlösser, R, 2007) |
| "However, aplastic anemia due to HIV infection is rare and even more so in children." | 1.33 | Aplastic anemia in an HIV infected child. ( Murthy, AK; Shah, I, 2005) |
| " One patient erroneously took double dosing of nevirapine, while the other patient did not attend the scheduled laboratory control two weeks after the initiation of nevirapine treatment." | 1.33 | [Hepatic failure due to nevirapine treatment for HIV infection]. ( Katzenstein, TL; Mens, H, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (10.59) | 18.2507 |
| 2000's | 39 (45.88) | 29.6817 |
| 2010's | 34 (40.00) | 24.3611 |
| 2020's | 3 (3.53) | 2.80 |
| Authors | Studies |
|---|---|
| Penda, CI | 1 |
| Moukoko Mbonjo, M | 1 |
| Fokam, J | 1 |
| Djeuda, ABD | 1 |
| Grace, N | 1 |
| Ateba Ndongo, F | 1 |
| Bilong, S | 1 |
| Eyoum Bille, B | 1 |
| Koki Ndombo, P | 1 |
| Aghokeng, A | 1 |
| Ndjolo, A | 1 |
| Eboumbou Moukoko, CE | 1 |
| Mulisa, D | 1 |
| Tesfa, M | 1 |
| Mullu Kassa, G | 1 |
| Tolossa, T | 1 |
| Celerino da Silva, R | 1 |
| Segat, L | 1 |
| Kuhn, L | 1 |
| Chies, JAB | 1 |
| Crovella, S | 1 |
| Flynn, PM | 1 |
| Taha, TE | 2 |
| Cababasay, M | 1 |
| Butler, K | 1 |
| Fowler, MG | 2 |
| Mofenson, LM | 1 |
| Owor, M | 1 |
| Fiscus, S | 2 |
| Stranix-Chibanda, L | 2 |
| Coutsoudis, A | 1 |
| Gnanashanmugam, D | 1 |
| Chakhtoura, N | 1 |
| McCarthy, K | 1 |
| Frenkel, L | 2 |
| Beck, I | 1 |
| Mukuzunga, C | 1 |
| Makanani, B | 1 |
| Moodley, D | 1 |
| Nematadzira, T | 1 |
| Kusakara, B | 1 |
| Patil, S | 1 |
| Vhembo, T | 1 |
| Bobat, R | 1 |
| Mmbaga, BT | 1 |
| Masenya, M | 1 |
| Nyati, M | 1 |
| Theron, G | 1 |
| Mulenga, H | 1 |
| Shapiro, DE | 2 |
| Hirapara, HN | 1 |
| Patel, TK | 1 |
| Barvaliya, MJ | 1 |
| Tripathi, C | 1 |
| Gandhi, M | 1 |
| Devi, S | 1 |
| Bacchetti, P | 1 |
| Chandy, S | 2 |
| Heylen, E | 2 |
| Phung, N | 1 |
| Kuncze, K | 1 |
| Okochi, H | 1 |
| Kumar, R | 1 |
| Kurpad, AV | 1 |
| Ekstrand, ML | 1 |
| Omooja, J | 1 |
| Nannyonjo, M | 1 |
| Sanyu, G | 1 |
| Nabirye, SE | 1 |
| Nassolo, F | 1 |
| Lunkuse, S | 1 |
| Kapaata, A | 1 |
| Segujja, F | 1 |
| Kateete, DP | 1 |
| Ssebaggala, E | 1 |
| Bbosa, N | 1 |
| Aling, E | 1 |
| Nsubuga, RN | 1 |
| Kaleebu, P | 1 |
| Ssemwanga, D | 1 |
| Tseng, A | 1 |
| Hills-Nieminen, C | 1 |
| Balkus, JE | 1 |
| Richardson, BA | 2 |
| Mochache, V | 1 |
| Chohan, V | 1 |
| Chan, JD | 1 |
| Masese, L | 1 |
| Shafi, J | 1 |
| Marrazzo, J | 1 |
| Farquhar, C | 2 |
| McClelland, RS | 1 |
| Kourtis, AP | 1 |
| Wiener, J | 1 |
| Kayira, D | 1 |
| Chasela, C | 1 |
| Ellington, SR | 1 |
| Hyde, L | 1 |
| Hosseinipour, M | 2 |
| van der Horst, C | 1 |
| Jamieson, DJ | 1 |
| Abgrall, S | 2 |
| Ingle, SM | 1 |
| May, MT | 1 |
| Costagliola, D | 2 |
| Mercie, P | 1 |
| Cavassini, M | 1 |
| Reekie, J | 1 |
| Samji, H | 1 |
| Gill, MJ | 1 |
| Crane, HM | 1 |
| Tate, J | 2 |
| Sterling, TR | 1 |
| Antinori, A | 2 |
| Reiss, P | 2 |
| Saag, MS | 1 |
| Mugavero, MJ | 1 |
| Phillips, A | 2 |
| Manzardo, C | 1 |
| Wasmuth, JC | 1 |
| Stephan, C | 1 |
| Guest, JL | 1 |
| Gomez Sirvent, JL | 1 |
| Sterne, JA | 2 |
| Ramokolo, V | 1 |
| Lombard, C | 1 |
| Fadnes, LT | 1 |
| Doherty, T | 1 |
| Jackson, DJ | 1 |
| Goga, AE | 1 |
| Chhagan, M | 1 |
| Van den Broeck, J | 1 |
| Gare, J | 1 |
| Ryan, CE | 1 |
| David, M | 1 |
| Timbi, D | 1 |
| Kaima, P | 1 |
| Kombati, Z | 1 |
| Imara, U | 1 |
| Kelly-Hanku, A | 1 |
| Siba, PM | 1 |
| Crowe, SM | 1 |
| Hearps, AC | 1 |
| Izudi, J | 1 |
| Alioni, S | 1 |
| Kerukadho, E | 1 |
| Ndungutse, D | 1 |
| Kasenga, F | 1 |
| Hurtig, AK | 1 |
| Emmelin, M | 1 |
| Samuel, MI | 1 |
| Tenant-Flowers, M | 1 |
| Kumar, U | 1 |
| Taylor, C | 1 |
| Chung, MH | 1 |
| Kiarie, JN | 1 |
| Lehman, DA | 1 |
| Overbaugh, J | 1 |
| Kinuthia, J | 1 |
| Njiri, F | 1 |
| John-Stewart, GC | 1 |
| Rutta, E | 1 |
| Gongo, R | 1 |
| Mwansasu, A | 1 |
| Mutasingwa, D | 1 |
| Rwegasira, V | 1 |
| Kishumbu, S | 1 |
| Tabayi, J | 1 |
| Masini, T | 1 |
| Ramadhani, H | 1 |
| Griffon, C | 1 |
| Gaertner, S | 1 |
| Mirea, C | 1 |
| Welsch, M | 1 |
| Stephan, D | 1 |
| Averbuch, D | 1 |
| Jaouni, T | 1 |
| Pe'er, J | 1 |
| Engelhard, D | 1 |
| Lawson-Evi, K | 1 |
| Mouhari-Toure, A | 1 |
| Tchama, R | 1 |
| Akakpo, SA | 1 |
| Atakouma, DY | 2 |
| Beauvais, L | 1 |
| Pitche, P | 1 |
| Dorton, BJ | 1 |
| Mulindwa, J | 1 |
| Li, MS | 1 |
| Chintu, NT | 1 |
| Chibwesha, CJ | 1 |
| Mbewe, F | 1 |
| Frenkel, LM | 1 |
| Stringer, JS | 2 |
| Chi, BH | 1 |
| Theron, GB | 1 |
| Van Dyke, R | 1 |
| Cababasay, MP | 1 |
| Louw, J | 1 |
| Watts, DH | 1 |
| Smith, E | 1 |
| Bulterys, M | 1 |
| Maupin, R | 1 |
| Østergaard, LR | 1 |
| Bula, A | 1 |
| Pérez Pedrero, D | 1 |
| Górgolas, M | 1 |
| Fernández Guerrero, ML | 1 |
| Sow, PG | 1 |
| Dia, AT | 1 |
| Diallo, PD | 1 |
| Gaye, AM | 1 |
| Schouten, EJ | 1 |
| Jahn, A | 1 |
| Midiani, D | 1 |
| Makombe, SD | 1 |
| Mnthambala, A | 1 |
| Chirwa, Z | 1 |
| Harries, AD | 2 |
| van Oosterhout, JJ | 1 |
| Meguid, T | 1 |
| Ben-Smith, A | 1 |
| Zachariah, R | 2 |
| Lynen, L | 1 |
| Zolfo, M | 1 |
| Van Damme, W | 1 |
| Gilks, CF | 1 |
| Atun, R | 1 |
| Shawa, M | 1 |
| Chimbwandira, F | 1 |
| Soria, J | 1 |
| Bull, M | 1 |
| Mitchell, C | 1 |
| La Rosa, A | 1 |
| Dross, S | 1 |
| Kraft, K | 1 |
| Coombs, R | 1 |
| Ticona, E | 1 |
| Baan, E | 1 |
| de Ronde, A | 1 |
| Luchters, S | 1 |
| Vyankandondera, J | 1 |
| Lange, JM | 1 |
| Pollakis, G | 1 |
| Paxton, WA | 1 |
| Stuart, GS | 1 |
| Moses, A | 1 |
| Corbett, A | 1 |
| Phiri, G | 1 |
| Kumwenda, W | 1 |
| Mkandawire, N | 1 |
| Chintedze, J | 1 |
| Malunga, G | 1 |
| Cohen, MS | 1 |
| Stanczyk, FZ | 1 |
| Kashuba, AD | 1 |
| Vallabhaneni, S | 1 |
| Ekstrand, M | 1 |
| Aizire, J | 1 |
| Wang, J | 1 |
| Shetty, AK | 1 |
| Kamateeka, M | 1 |
| Brown, ER | 1 |
| Bolton, SG | 1 |
| Musoke, PM | 1 |
| Coovadia, H | 1 |
| Belda, A | 1 |
| Borrás-Blasco, J | 1 |
| Rosique-Robles, D | 1 |
| Jiménez, I | 1 |
| López-Montes, L | 1 |
| Casterá, E | 1 |
| Koudoukpo, C | 1 |
| Yédomon, GH | 1 |
| Adégbidi, H | 2 |
| Atadokpédé, F | 1 |
| Do Ango-Padonou, F | 1 |
| Cain, LE | 1 |
| Lodi, S | 1 |
| Sabin, C | 1 |
| Bansi, L | 1 |
| Justice, A | 1 |
| Logan, R | 1 |
| Robins, JM | 1 |
| van Sighem, A | 1 |
| de Wolf, F | 1 |
| Bucher, HC | 1 |
| Elzi, L | 1 |
| Touloumi, G | 1 |
| Vourli, G | 1 |
| Esteve, A | 1 |
| Casabona, J | 1 |
| del Amo, J | 1 |
| Moreno, S | 1 |
| Seng, R | 1 |
| Meyer, L | 1 |
| Pérez-Hoyos, S | 1 |
| Muga, R | 1 |
| Hernán, MA | 1 |
| Fillekes, Q | 1 |
| Mulenga, V | 1 |
| Kabamba, D | 1 |
| Kankasa, C | 1 |
| Thomason, MJ | 1 |
| Cook, A | 1 |
| Ferrier, A | 1 |
| Chintu, C | 1 |
| Walker, AS | 1 |
| Gibb, DM | 1 |
| Burger, DM | 1 |
| Guidi, M | 1 |
| Arab-Alameddine, M | 1 |
| Rotger, M | 2 |
| Aouri, M | 1 |
| Telenti, A | 2 |
| Decosterd, LA | 1 |
| Buclin, T | 2 |
| Csajka, C | 1 |
| Feeney, ER | 1 |
| van Vonderen, MG | 1 |
| Wit, F | 1 |
| Danner, SA | 1 |
| van Agtmael, MA | 1 |
| Villarroya, F | 1 |
| Domingo, P | 1 |
| Capeau, J | 1 |
| Mallon, PW | 1 |
| Ram, M | 1 |
| Gupte, N | 1 |
| Nayak, U | 1 |
| Kinikar, AA | 1 |
| Khandave, M | 1 |
| Shankar, AV | 1 |
| Sastry, J | 1 |
| Bollinger, RC | 1 |
| Gupta, A | 1 |
| Ford, N | 1 |
| Calmy, A | 1 |
| Andrieux-Meyer, I | 1 |
| Hargreaves, S | 1 |
| Mills, EJ | 1 |
| Shubber, Z | 1 |
| Saka, B | 1 |
| Barro-Traoré, F | 1 |
| Atadokpédé, FA | 1 |
| Kobangue, L | 1 |
| Niamba, PA | 1 |
| Yedomon, HG | 1 |
| Traoré, A | 1 |
| Pitché, VP | 1 |
| Liu, L | 1 |
| Wang, L | 1 |
| Huang, L | 1 |
| Siu, V | 1 |
| Teque, F | 1 |
| Aweeka, FT | 1 |
| Levy, JA | 1 |
| Sidley, P | 1 |
| Foster, R | 1 |
| Olajide, D | 1 |
| Everall, IP | 1 |
| Pérez-Simón, MR | 1 |
| Cuevas, MJ | 1 |
| Ortega, L | 1 |
| Carro, JA | 1 |
| Mostaza, JL | 1 |
| Martín, V | 1 |
| Sinkala, M | 1 |
| Chapman, V | 1 |
| Acosta, EP | 1 |
| Aldrovandi, GM | 1 |
| Mudenda, V | 1 |
| Stout, JP | 1 |
| Goldenberg, RL | 1 |
| Kumwenda, R | 1 |
| Vermund, SH | 1 |
| Kumwenda, NI | 1 |
| Gibbons, A | 1 |
| Broadhead, RL | 1 |
| Lema, V | 1 |
| Liomba, G | 1 |
| Nkhoma, C | 1 |
| Miotti, PG | 1 |
| Hoover, DR | 1 |
| Crabb, C | 1 |
| Plana, M | 1 |
| Ferrer, E | 1 |
| Martínez, C | 1 |
| Podzamczer, D | 1 |
| García, F | 1 |
| Maleno, MJ | 1 |
| Barceló, JJ | 1 |
| García, A | 1 |
| Barberá, MJ | 1 |
| Lacarcel, M | 1 |
| Miró, JM | 1 |
| Gallart, T | 1 |
| Gatell, JM | 1 |
| Kravchenko, AV | 1 |
| Miroshnichenko, AV | 1 |
| Beliaeva, VV | 1 |
| Serebrovskaia, LV | 1 |
| Bogoslovskaia, EV | 1 |
| Sitdykova, IuR | 1 |
| Ananworanich, J | 1 |
| Moor, Z | 1 |
| Siangphoe, U | 1 |
| Chan, J | 1 |
| Cardiello, P | 1 |
| Duncombe, C | 1 |
| Phanuphak, P | 1 |
| Ruxrungtham, K | 1 |
| Lange, J | 1 |
| Cooper, DA | 2 |
| Johnson, N | 1 |
| Mullings, AA | 1 |
| Harvey, KM | 1 |
| Alexander, G | 1 |
| McDonald, D | 1 |
| Smikle, MF | 1 |
| Williams, E | 1 |
| Palmer, P | 1 |
| Whorms, S | 1 |
| Figueroa, JP | 1 |
| Christie, CD | 1 |
| Teck, R | 1 |
| Ascurra, O | 1 |
| Gomani, P | 1 |
| Manzi, M | 1 |
| Humblet, P | 1 |
| Nunn, P | 1 |
| Salaniponi, FM | 1 |
| Sint, TT | 1 |
| Dabis, F | 1 |
| Kamenga, C | 1 |
| Shaffer, N | 1 |
| de Zoysa, IF | 1 |
| Newell, ML | 1 |
| Colombo, S | 1 |
| Furrer, H | 1 |
| Bleiber, G | 1 |
| Lee, BL | 1 |
| Keiser, O | 1 |
| Biollaz, J | 1 |
| Décosterd, L | 1 |
| Shah, I | 1 |
| Murthy, AK | 1 |
| Mens, H | 1 |
| Katzenstein, TL | 1 |
| Simpore, J | 1 |
| Pietra, V | 1 |
| Savadogo, A | 1 |
| Pignatelli, S | 1 |
| Nikiema, JB | 1 |
| Nadembega, WM | 1 |
| Yara, J | 1 |
| Zoungrana, N | 1 |
| Bakouan, D | 1 |
| Colizzi, V | 1 |
| Castelli, F | 1 |
| Musumeci, S | 1 |
| Schmitz, T | 1 |
| Weizsaecker, K | 1 |
| Feiterna-Sperling, C | 1 |
| Eilers, E | 1 |
| Obladen, M | 1 |
| Winston, A | 1 |
| Amin, J | 1 |
| Hales, G | 1 |
| Emery, S | 1 |
| Geffen, N | 1 |
| Nattrass, N | 1 |
| Gray, G | 1 |
| Drummond, NS | 1 |
| Vilar, FJ | 1 |
| Naisbitt, DJ | 1 |
| Hanson, A | 1 |
| Woods, A | 1 |
| Park, BK | 1 |
| Pirmohamed, M | 1 |
| Homsy, J | 1 |
| Kalamya, JN | 1 |
| Obonyo, J | 1 |
| Ojwang, J | 1 |
| Mugumya, R | 1 |
| Opio, C | 1 |
| Mermin, J | 1 |
| Sagay, AS | 1 |
| Musa, J | 1 |
| Adewole, AS | 1 |
| Imade, GE | 1 |
| Ekwempu, CC | 1 |
| Kapiga, S | 1 |
| Sankale, JL | 1 |
| Idoko, J | 1 |
| Kanki, P | 1 |
| Jamisse, L | 1 |
| Balkus, J | 1 |
| Hitti, J | 1 |
| Gloyd, S | 1 |
| Manuel, R | 1 |
| Osman, N | 1 |
| Djedje, M | 1 |
| Anastos, K | 1 |
| Lu, D | 1 |
| Shi, Q | 1 |
| Tien, PC | 1 |
| Kaplan, RC | 1 |
| Hessol, NA | 1 |
| Cole, S | 1 |
| Vigen, C | 1 |
| Cohen, M | 1 |
| Young, M | 1 |
| Justman, J | 1 |
| Djadou, KE | 1 |
| Ocloo, A | 1 |
| Dokounor, D | 1 |
| Agbodjan-Djossou, O | 1 |
| Akakpossa, A | 1 |
| Schlösser, R | 1 |
| Linde, R | 1 |
| Dunsch, D | 1 |
| Reitter, A | 1 |
| Haberl, A | 1 |
| Bauer, K | 1 |
| Havlir, D | 1 |
| McLaughlin, MM | 1 |
| Richman, DD | 1 |
| Leavitt, MC | 1 |
| Yu, M | 1 |
| Wong-Staal, F | 1 |
| Looney, DJ | 1 |
| Shafer, RW | 1 |
| Eisen, JA | 1 |
| Merigan, TC | 2 |
| Katzenstein, DA | 1 |
| Gómez-Cano, M | 1 |
| Soriano, V | 1 |
| Aldeen, T | 1 |
| Hay, P | 1 |
| Davidson, F | 1 |
| Lau, R | 1 |
| Van der Ven, AJ | 1 |
| Jacobs, JA | 1 |
| Schrey, G | 1 |
| Lawrence, J | 1 |
| Schapiro, J | 1 |
| Winters, M | 1 |
| Montoya, J | 1 |
| Zolopa, A | 1 |
| Pesano, R | 1 |
| Efron, B | 1 |
| Winslow, D | 1 |
| Wetterwald, E | 1 |
| Le Cleach, L | 1 |
| Michel, C | 1 |
| David, F | 1 |
| Revuz, J | 1 |
| Masland, T | 1 |
| King, P | 1 |
| Pinto, JL | 1 |
| López Lavid, C | 1 |
| Badia, X | 1 |
| Coma, A | 1 |
| Benavides, A | 1 |
| Lhotska, L | 1 |
| Armstrong, H | 1 |
| Baleta, A | 3 |
| Zaccarelli, M | 1 |
| Barracchini, A | 1 |
| De Longis, P | 1 |
| Perno, CF | 1 |
| Soldani, F | 1 |
| Liuzzi, G | 1 |
| Serraino, D | 1 |
| Ippolito, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Short Duration Exclusive Breastfeeding With Abrupt Weaning to Reduce the Risk of Mother-to-Child HIV Transmission[NCT00310726] | 1,435 participants (Actual) | Interventional | 2001-05-31 | Completed | |||
| EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV[NCT02699736] | 23,000 participants (Actual) | Observational [Patient Registry] | 1994-01-31 | Enrolling by invitation | |||
| PROMISE EBF: Promoting Infant Health and Nutrition in Sub-Saharan Africa: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV[NCT00397150] | 2,579 participants (Actual) | Interventional | 2006-11-30 | Completed | |||
| ARVs to Prevent Breastmilk HIV:Viral and Immune Responses[NCT00167674] | Phase 2 | 58 participants (Actual) | Interventional | 2003-05-31 | Completed | ||
| Addition of Single-dose, Maternal Tenofovir and Emtricitabine to Reduce Non-nucleoside Reverse Transcriptase Inhibitor Resistance Mutations in the Setting of Zidovudine and Nevirapine for Prevention of Mother-to-child HIV Transmission[NCT00204308] | Phase 2 | 400 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| Tel-Me-Box: Validating and Testing a Novel, Low-cost, Real-time Monitoring Device With Hair Level Analysis Among Adherence-challenged Patients[NCT03086655] | 131 participants (Actual) | Interventional | 2021-08-13 | Completed | |||
| A Phase III Trial to Determine the Efficacy and Safety of an Extended Regimen of Nevirapine in Infants Born to HIV-Infected Women to Prevent Vertical HIV Transmission During Breastfeeding[NCT00074412] | Phase 3 | 2,026 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| Prevention of Maternal to Infant HIV Transmission in India[NCT00061321] | Phase 3 | 770 participants (Actual) | Interventional | 2002-08-31 | Completed | ||
| An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3[NCT00000747] | Phase 2 | 10 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The EBF prevalences (24-h recall) at 12 weeks in the intervention and control clusters. (NCT00397150)
Timeframe: at 3 months of age
| Intervention | participants (Number) |
|---|---|
| Intervention | 310 |
| No Intervention | 161 |
The EBF prevalences based on 24-h recall at 12 weeks in the intervention and control clusters. (NCT00397150)
Timeframe: at 3 months of age
| Intervention | participants (Number) |
|---|---|
| Intervention | 56 |
| No Intervention | 30 |
The EBF prevalences (24-h recall) at 12 weeks in the intervention and control clusters. (NCT00397150)
Timeframe: at 3 months of age
| Intervention | participants (Number) |
|---|---|
| Intervention | 323 |
| No Intervention | 161 |
(NCT00397150)
Timeframe: at 3 months of age
| Intervention | participants (Number) |
|---|---|
| Intervention | 104 |
| No Intervention | 101 |
For those infants who were randomized at 6 weeks and who initiated study drug we looked at the frequency and severity of adverse reactions through 18 months of study. The severity of all AEs was graded according to the DAIDS Table for Grading the Severity of Adult and Pediatric Adverse Events. The term severity is described as the intensity grade or level for specific event (i.e. mild, moderate, severe, or life-threatening). Severity is not the same as seriousness. (NCT00074412)
Timeframe: 6 weeks through 18 months
| Intervention | Number of Adverse Events (Number) | ||||
|---|---|---|---|---|---|
| Death | Life-Threatening | Severe | Moderate | Mild | |
| Nevirapine | 26 | 87 | 375 | 694 | 832 |
| Placebo | 30 | 87 | 332 | 677 | 838 |
(NCT00074412)
Timeframe: At Month 6
| Intervention | participants (Number) | |
|---|---|---|
| # of HIV infections at 6 months | # of Infants at risk for HIV infection at 6 months | |
| Nevirapine | 8 | 700 |
| Placebo | 18 | 699 |
(NCT00074412)
Timeframe: At Month 18
| Intervention | participants (Number) | |
|---|---|---|
| # Infant Deaths at 18 months | # Infants at risk of death at 18 months | |
| Nevirapine | 26 | 678 |
| Placebo | 30 | 684 |
(NCT00074412)
Timeframe: At Months 6 and 18
| Intervention | participants (Number) | |
|---|---|---|
| Number of Infants Alive and HIV-free at 6 months | Number of Infants Alive and HIV-free at 18 months | |
| Nevirapine | 689 | 629 |
| Placebo | 683 | 616 |
(NCT00074412)
Timeframe: At Month 18
| Intervention | participants (Number) | |
|---|---|---|
| # of infants with HIV infection at 18 months | # of infants @ risk for HIV infection at 18 months | |
| Nevirapine | 16 | 664 |
| Placebo | 23 | 663 |
5 reviews available for nevirapine and AIDS Seroconversion
| Article | Year |
|---|---|
Drug interactions between antiretrovirals and hormonal contraceptives.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Drug Interactio | 2013 |
Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Seropositivity; Humans; Nevirapine; Pregna | 2013 |
Antiretroviral therapy-induced psychosis: case report and brief review of the literature.
Topics: Adult; Antipsychotic Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combina | 2003 |
Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Drug Therapy, Combina | 2005 |
[Resistance to antiretroviral drugs].
Topics: Antiviral Agents; Drug Resistance; Drug Resistance, Multiple; HIV Seropositivity; HIV-1; Humans; Lam | 1997 |
18 trials available for nevirapine and AIDS Seroconversion
| Article | Year |
|---|---|
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component.
Topics: Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Female; HIV Infections; HIV Seropositivity; H | 2021 |
Health outcomes of HIV-exposed uninfected African infants.
Topics: Anti-Retroviral Agents; Antiviral Agents; Breast Feeding; Cause of Death; Drug Therapy, Combination; | 2013 |
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Seroposit | 2008 |
CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinatal HIV prevention.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Resistance, Viral; Female; HIV Infections; HIV Seroposit | 2011 |
Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa.
Topics: Adolescent; Adult; Anti-HIV Agents; Cluster Analysis; Feasibility Studies; Female; HIV Infections; H | 2011 |
Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Contraceptives, Oral, Combined; Drug Therapy, Combination; | 2011 |
Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated.
Topics: Adult; Anemia; Anti-HIV Agents; Blotting, Western; Breast Feeding; Drug Administration Schedule; Dru | 2012 |
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; Drug Administration Schedule; D | 2012 |
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents | 2012 |
Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India.
Topics: Adult; Anthropometry; Female; HIV Infections; HIV Seropositivity; Humans; India; Infant; Infant, New | 2012 |
Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine.
Topics: Adolescent; Adult; Breast Feeding; Drug Administration Schedule; Female; HIV Infections; HIV Seropos | 2003 |
Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
Topics: Anti-HIV Agents; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infan | 2003 |
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Topics: Adult; Aged; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Administr | 2004 |
Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs.
Topics: Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Administration Schedule; Dru | 2005 |
Reduction of mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
Topics: Adolescent; Adult; Anti-HIV Agents; Bottle Feeding; Breast Feeding; Burkina Faso; Drug Administratio | 2006 |
Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens.
Topics: Adult; Alanine Transaminase; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asparta | 2007 |
A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of > 500/mm3: AIDS Clinical Trials Group Protocol 208.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Resistance, Microbial; Female | 1995 |
Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons.
Topics: Adult; Drug Resistance; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV Seropo | 1999 |
62 other studies available for nevirapine and AIDS Seroconversion
| Article | Year |
|---|---|
Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon.
Topics: Adolescent; Anti-HIV Agents; Cameroon; Drug Resistance, Viral; Follow-Up Studies; Health Facilities; | 2022 |
Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: un-matched case control study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; Case-Control Studies; CD4 Lymphoc | 2019 |
Association of SNPs in HLA-C and ZNRD1 Genes With HIV-1 Mother-to-Child Transmission in Zambia Population.
Topics: Adult; Anti-HIV Agents; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Genotype; H | 2021 |
Drug-induced Stevens-Johnson syndrome in Indian population: A multicentric retrospective analysis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Analgesics; Anti-Bacterial Agents; Anticonvulsants | 2017 |
Measuring Adherence to Antiretroviral Therapy via Hair Concentrations in India.
Topics: Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Dru | 2019 |
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; H | 2019 |
A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
Topics: Adult; Anti-HIV Agents; Antiprotozoal Agents; Cohort Studies; Drug Therapy, Combination; Female; HIV | 2013 |
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009.
Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studi | 2013 |
HIV infection, viral load, low birth weight, and nevirapine are independent influences on growth velocity in HIV-exposed South African infants.
Topics: Adolescent; Adult; Anti-HIV Agents; Black People; Female; Growth Disorders; HIV; HIV Infections; HIV | 2014 |
Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cy | 2014 |
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Weight; CD4-Positive T-Lymphocytes; Cohort Studi | 2016 |
HIV-positive women's experiences of a PMTCT programme in rural Malawi.
Topics: Anti-HIV Agents; Choice Behavior; Disclosure; Female; Health Knowledge, Attitudes, Practice; Health | 2010 |
Two for the price of one.
Topics: Adult; Anemia; Anti-HIV Agents; Contraceptive Agents, Female; Drug Therapy, Combination; Endometrios | 2008 |
Prevention of mother-to-child transmission of HIV in a refugee camp setting in Tanzania.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infecti | 2008 |
[Inefficacy of vitamin K antagonists in an human immunodeficiency virus seropositive patient taking nevirapine].
Topics: Anticoagulants; Drug Interactions; Female; HIV Seropositivity; Humans; Middle Aged; Nevirapine; Phen | 2009 |
Confluent molluscum contagiosum covering the eyelids of an HIV-positive child.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Drug Therapy, Combination; Eye Infections, | 2009 |
[Fate of children born to HIV positive mothers followed in the context of preventing mother-to-child transmission of HIV in Togo. Study of 1042 infants].
Topics: Anti-HIV Agents; Breast Feeding; Delivery, Obstetric; Female; HIV Infections; HIV Seropositivity; Hu | 2010 |
"They call our children "Nevirapine babies?" ": A qualitative study about exclusive breastfeeding among HIV positive mothers in Malawi.
Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Family; Female; Health Knowledge, Attitudes, Pra | 2010 |
Nevirapine-induced agranulocytosis.
Topics: Agranulocytosis; Anti-HIV Agents; HIV; HIV Seropositivity; Humans; Male; Middle Aged; Nevirapine | 2011 |
[Comparative study of two anti-antiretroviral protocols used for treatment of a cohort of HIV 1-positive patients followed at the Institute of Public Health and Hygiene in Dakar, Senegal].
Topics: Academies and Institutes; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazi | 2011 |
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.
Topics: Adult; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Administration Schedule; Drug The | 2011 |
Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Seropositivity; HIV-1; Humans; Longitudi | 2012 |
HIV type 1 mother-to-child transmission facilitated by distinctive glycosylation sites in the gp120 envelope glycoprotein.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Cohort Studies; Female; Glycosylation; HIV Envelope Protein | 2012 |
Reasons for and correlates of antiretroviral treatment interruptions in a cohort of patients from public and private clinics in southern India.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort St | 2012 |
Hyperhidrosis related to nevirapine therapy.
Topics: Adenine; Aged; Anti-HIV Agents; Drug Eruptions; HIV Seropositivity; Humans; Hyperhidrosis; Lamivudin | 2012 |
[Erosive and budding molluscum contagiosum: total regression under antiretroviral therapy].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Benin; Drug Therapy, Combination; Fem | 2012 |
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Administrat | 2012 |
Dosage optimization of treatments using population pharmacokinetic modeling and simulation.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Cohort S | 2012 |
Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
Topics: Adolescent; Adult; Africa South of the Sahara; Aged; Aged, 80 and over; AIDS-Related Opportunistic I | 2013 |
Nevirapine inhibits the anti-HIV activity of CD8+ cells.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Coculture | 2013 |
South African government forced to give mothers antiretroviral drug.
Topics: Anti-HIV Agents; Female; HIV Seropositivity; Humans; Legislation, Drug; Nevirapine; Pregnancy; Rever | 2002 |
[Assessment of adherence to antiretroviral: role of determination of plasma levels of non nucleosides anologues].
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cross-Sectiona | 2003 |
Breastfeeding and HIV transmission.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Seropositivity; Humans; Infant; Lamivudine; Nevirapine; | 2003 |
[Antiretroviral therapy of acute HIV-infection].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; HIV Infect | 2004 |
HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in greater Kingston, Jamaica.
Topics: Adolescent; Adult; Female; HIV Infections; HIV Seropositivity; HIV Seroprevalence; Humans; Infectiou | 2004 |
Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?
Topics: Anti-HIV Agents; Female; Health Status; HIV Infections; HIV Seropositivity; Humans; Infectious Disea | 2005 |
Routine provision of nevirapine to women of unknown serostatus: at best a temporary solution to prevent MTCT.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infe | 2005 |
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.
Topics: Adult; Alkynes; Alleles; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes | 2005 |
Aplastic anemia in an HIV infected child.
Topics: Adolescent; Anemia, Aplastic; Anti-HIV Agents; Blotting, Western; Enzyme-Linked Immunosorbent Assay; | 2005 |
[Hepatic failure due to nevirapine treatment for HIV infection].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Fatal Outcome; Female; HIV Seropositi | 2005 |
Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates.
Topics: Anti-HIV Agents; Enterocolitis, Necrotizing; HIV Seropositivity; Humans; Infant, Newborn; Lamivudine | 2006 |
Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Follow-Up Studies; HIV Seropo | 2006 |
HIV denialists ignore large gap in the study they cite.
Topics: Clinical Trials as Topic; Denial, Psychological; Female; History, 20th Century; HIV Infections; HIV | 2006 |
Drug-specific T cells in an HIV-positive patient with nevirapine-induced hepatitis.
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; HIV Seropositivity; HIV-1; Humans; M | 2006 |
Routine intrapartum HIV counseling and testing for prevention of mother-to-child transmission of HIV in a rural Ugandan hospital.
Topics: Anti-HIV Agents; Counseling; Feasibility Studies; Female; HIV Infections; HIV Seropositivity; Humans | 2006 |
Rapid HIV testing and counselling in labour in a northern Nigerian setting.
Topics: Adolescent; Adult; Anti-HIV Agents; Counseling; Cross-Sectional Studies; Female; HIV Infections; HIV | 2006 |
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black | 2007 |
[Treatment of children born of AIDS mothers in Tsevie hospital regional center, Togo].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Breast Feeding; Child Health Services; Femal | 2007 |
[Side effects of antiretroviral treatment for transmission prophylaxis in preterm and near-term infants].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cesarean Section; Female; Gestational Age; HIV | 2007 |
Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial.
Topics: Animals; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Survival; Cel | 1996 |
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
Topics: Adult; Amino Acid Sequence; Base Sequence; Didanosine; DNA, Viral; Female; Genes, env; HIV Reverse T | 1997 |
Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy.
Topics: Anti-HIV Agents; CD4-CD8 Ratio; Herpes Zoster; Herpesvirus 3, Human; HIV Protease Inhibitors; HIV Se | 1998 |
[Infection with Mycobacterium genavense in 2 HIV-seropositive patients in Amsterdam].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Drug Interactio | 1998 |
Nevirapine-induced overlap stevens-johnson syndrome/toxic epidermal necrolysis.
Topics: Adult; Anti-HIV Agents; HIV Seropositivity; Humans; Male; Nevirapine; Stevens-Johnson Syndrome | 1999 |
Nevirapine and methadone withdrawal.
Topics: Anti-HIV Agents; Drug Interactions; HIV Seropositivity; Humans; Methadone; Narcotics; Nevirapine; Su | 1999 |
Flirting with strange ideas. Mbeki reaches out to a controversial AIDS researcher.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Biochemistry; Clinical Trials as Topic; | 2000 |
[Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients].
Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Didanosine; Drug Therapy, Combination; Female; HIV Se | 2000 |
Future directions.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Bottle Feeding; Breast Feeding; Counseling; Fem | 2000 |
South Africa's AIDS activists say new neviripine programme is not enough.
Topics: Anti-HIV Agents; Costs and Cost Analysis; Female; Financing, Government; Health Care Rationing; HIV | 2001 |
Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Feasibility Studies; Female; HIV Sero | 2002 |
South African judge reaffirms judgement to expand access to AIDS drug.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission | 2002 |
South African court again tells government to increase access to AIDS drug.
Topics: Anti-HIV Agents; Female; Health Policy; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; | 2002 |